ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Vyome Holdings, Inc.
3.41
+0.0400
1.19%
成交量:
4.81万
成交额:
15.99万
市值:
1,924.77万
市盈率:
-0.02
高:
3.45
开:
3.28
低:
3.28
收:
3.37
52周最高:
305.00
52周最低:
1.75
股本:
564.45万
流通股本:
309.91万
量比:
0.31
换手率:
1.55%
股息:
- -
股息率:
- -
每股收益(TTM):
-183.1419
每股收益(LYR):
-0.7646
净资产收益率:
--
总资产收益率:
-24.52%
市净率:
7.61
市盈率(LYR):
-4.46
数据加载中...
总览
公司
新闻资讯
公告
Livechain完成对MIT孵化AI人力资源分析公司Humanyze优先担保债务的收购
美股速递
·
02/24
Vyome为Vt-1953申请孤儿药资格认定,未来六个月将深化该项目的战略布局
美股速递
·
02/11
独立分析师评估:Vyome旗下Vt-1953若三期研究成功,估值将达10亿美元
美股速递
·
01/27
Vyome Holdings, Inc.盘中异动 早盘大幅上涨5.97%报2.84美元
市场透视
·
01/22
Vyome Holdings, Inc.盘中异动 早盘急速拉升9.27%报3.30美元
市场透视
·
01/15
Vyome控股子公司LIVECHAIN INC.收购MIT孵化公司Humanyze的高级担保票据
美股速递
·
2025/12/22
Vyome Holdings, Inc.盘中异动 下午盘快速下挫6.11%
市场透视
·
2025/12/20
Vyome Holdings, Inc. - 将与FDA合作设计并启动2026年重要的三期临床研究
美股速递
·
2025/12/08
Vyome公布Vt-1953最终二期试验积极结果;计划推进至FDA批准的关键研究
美股速递
·
2025/12/08
Vyome Holdings Inc:VT-1953治疗恶性真菌创面的二期研究获得积极中期数据
美股速递
·
2025/09/04
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/HIND/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HIND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIND\",,,,,undefined,":{"symbol":"HIND","market":"US","secType":"STK","nameCN":"Vyome Holdings, Inc.","latestPrice":3.41,"timestamp":1772485200000,"preClose":3.37,"halted":0,"volume":48146,"delay":0,"changeRate":0.011869436201780426,"floatShares":3099100,"shares":5644494,"eps":-183.1419,"marketStatus":"盘前交易","change":0.04,"latestTime":"03-03 04:21:22 EST","open":3.28,"high":3.4459,"low":3.28,"amount":159927.0641038,"amplitude":0.049228,"askPrice":3.74,"askSize":100,"bidPrice":3,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-183.1419,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772548200000},"marketStatusCode":1,"adr":0,"listingDate":1475726400000,"exchange":"NASDAQ","adjPreClose":3.41,"postHourTrading":{"tag":"盘后","latestPrice":3.35,"preClose":3.41,"latestTime":"19:47 EST","volume":525,"amount":1730.36,"timestamp":1772498827614,"change":-0.06,"changeRate":-0.017595,"amplitude":0.020528},"volumeRatio":0.30845222927575044},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIND\",,,,,undefined,":{"symbol":"HIND","floatShares":3099100,"roa":"-24.52%","roe":"--","lyrEps":-0.76459,"volumeRatio":0.30845222927575044,"shares":5644494,"dividePrice":0,"high":3.4459,"amplitude":0.049228,"preClose":3.37,"low":3.28,"week52Low":1.75,"pbRate":"7.61","psRate":"55.86","week52High":305,"institutionHeld":0,"latestPrice":3.41,"committee":-0.980198,"eps":-183.1419,"divideRate":0,"volume":48146,"delay":0,"ttmEps":-183.1419,"open":3.28,"prevYearClose":3.44,"prevWeekClose":3.37,"prevMonthClose":3.37,"prevQuarterClose":3.44,"fiveDayClose":2.9,"twentyDayClose":1.92,"sixtyDayClose":4.955},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"HIND","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":-3.12},{"market":"US","date":"2025-08-15","symbol":"HIND","defaultRemindTime":1755264600000,"type":"split","dateTimestamp":1755230400000,"forFactor":4,"toFactor":1,"ratio":4},{"market":"US","date":"2025-08-14","symbol":"HIND","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-2.25},{"market":"US","date":"2025-05-21","symbol":"HIND","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1747800000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-05-09","symbol":"HIND","defaultRemindTime":1746797400000,"type":"split","dateTimestamp":1746763200000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIND\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1763701200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HIND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HIND","date":"2026-02-27","current":-0.018619,"percent":0.669231,"low":-23.816091,"twenty":-20.435747,"median":-3.008592,"eighty":-1.661371,"high":-0.001601,"avg":-9.109541,"sd":8.808272,"marketCap":18965499},"quantilePoints":[{"date":"2025-08-22","current":-12.854344,"twenty":-12.392244,"median":-11.699095,"eighty":-11.005946,"marketCap":20748595},{"date":"2025-08-29","current":-11.259279,"twenty":-13.22027,"median":-12.854344,"eighty":-11.500884,"marketCap":18173952},{"date":"2025-09-05","current":-9.124707,"twenty":-13.182739,"median":-11.259279,"eighty":-10.03366,"marketCap":14728473},{"date":"2025-09-12","current":-0.001997,"twenty":-12.854344,"median":-10.288753,"eighty":-0.00213,"marketCap":2910},{"date":"2025-09-19","current":-0.001751,"twenty":-12.467306,"median":-9.124707,"eighty":-0.001933,"marketCap":2551},{"date":"2025-09-26","current":-20.664803,"twenty":-13.499407,"median":-10.288753,"eighty":-0.001997,"marketCap":30109879},{"date":"2025-10-03","current":-20.473816,"twenty":-20.473816,"median":-11.259279,"eighty":-0.002098,"marketCap":29831599},{"date":"2025-10-10","current":-21.00858,"twenty":-21.00858,"median":-13.018541,"eighty":-0.002106,"marketCap":30610783},{"date":"2025-10-17","current":-19.327894,"twenty":-20.855791,"median":-13.499407,"eighty":-0.00213,"marketCap":28161920},{"date":"2025-10-24","current":-20.850495,"twenty":-20.850495,"median":-19.346992,"eighty":-0.002143,"marketCap":30380443},{"date":"2025-10-31","current":-21.039016,"twenty":-20.850495,"median":-19.786263,"eighty":-9.124707,"marketCap":30655130},{"date":"2025-11-07","current":-21.340651,"twenty":-21.039016,"median":-20.206435,"eighty":-10.010203,"marketCap":31094630},{"date":"2025-11-14","current":-18.588235,"twenty":-21.00858,"median":-20.168237,"eighty":-10.03366,"marketCap":27084192},{"date":"2025-11-21","current":-17.984966,"twenty":-21.00858,"median":-20.037322,"eighty":-10.543846,"marketCap":26205192},{"date":"2025-11-28","current":-3.129419,"twenty":-20.886349,"median":-19.767164,"eighty":-7.929274,"marketCap":29238478},{"date":"2025-12-05","current":-3.075047,"twenty":-20.851554,"median":-19.327894,"eighty":-3.104045,"marketCap":28730474},{"date":"2025-12-12","current":-2.881724,"twenty":-20.850495,"median":-18.663643,"eighty":-3.026716,"marketCap":26924236},{"date":"2025-12-19","current":-2.342231,"twenty":-20.820331,"median":-18.362009,"eighty":-2.975968,"marketCap":21883703},{"date":"2025-12-26","current":-2.271547,"twenty":-20.790168,"median":-17.381696,"eighty":-2.665444,"marketCap":21223297},{"date":"2026-01-02","current":-2.078224,"twenty":-20.744922,"median":-13.229653,"eighty":-2.363376,"marketCap":19417059},{"date":"2026-01-09","current":-2.072183,"twenty":-20.685727,"median":-12.660825,"eighty":-2.260673,"marketCap":19360614},{"date":"2026-01-16","current":-1.866777,"twenty":-20.618426,"median":-10.790143,"eighty":-2.104806,"marketCap":17441486},{"date":"2026-01-23","current":-1.761053,"twenty":-20.541319,"median":-10.03366,"eighty":-2.062517,"marketCap":16453700},{"date":"2026-01-30","current":-1.292849,"twenty":-20.511156,"median":-6.2932,"eighty":-1.940481,"marketCap":12079217},{"date":"2026-02-06","current":-1.38951,"twenty":-20.503688,"median":-3.129419,"eighty":-1.87886,"marketCap":12982336},{"date":"2026-02-13","current":-1.576792,"twenty":-20.469996,"median":-3.093171,"eighty":-1.729639,"marketCap":14732129},{"date":"2026-02-20","current":-1.661371,"twenty":-20.454717,"median":-3.029737,"eighty":-1.661371,"marketCap":15522358},{"date":"2026-02-27","current":-2.029893,"twenty":-20.435747,"median":-3.008592,"eighty":-1.661371,"marketCap":18965499}],"updateTime":1772529682661},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIND\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1182593137","title":"Livechain完成对MIT孵化AI人力资源分析公司Humanyze优先担保债务的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1182593137","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182593137?lang=zh_cn&edition=fundamental","pubTime":"2026-02-24 21:07","pubTimestamp":1771938423,"startTime":"0","endTime":"0","summary":"Livechain已正式完成对Humanyze公司优先担保债务的收购。Humanyze是一家由麻省理工学院孵化、采用人工智能技术的人力资源分析企业。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LICH","BK4007","BK4082","HIND"],"gpt_icon":0},{"id":"1108702394","title":"Vyome为Vt-1953申请孤儿药资格认定,未来六个月将深化该项目的战略布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1108702394","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108702394?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 20:06","pubTimestamp":1770811595,"startTime":"0","endTime":"0","summary":"Vyome Holdings, Inc. 已正式提交Vt-1953的孤儿药资格认定申请,此举标志着公司对该创新药项目的战略重视程度进一步提升。未来六个月内,企业计划集中资源推进Vt-1953项目的研发进程,强化其在特定疾病治疗领域的竞争优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4082","HIND"],"gpt_icon":0},{"id":"1186890961","title":"独立分析师评估:Vyome旗下Vt-1953若三期研究成功,估值将达10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186890961","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186890961?lang=zh_cn&edition=fundamental","pubTime":"2026-01-27 21:02","pubTimestamp":1769518963,"startTime":"0","endTime":"0","summary":"据独立分析师最新评估,若Vyome Holdings, Inc.研发的Vt-1953药物能顺利通过三期临床试验,其市场价值有望突破10亿美元大关。这一估值凸显了该创新疗法在医疗领域的巨大潜力,也为投资者提供了明确的价值参考。随着三期研究进入关键阶段,市场对Vt-1953的未来表现持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4007","HIND"],"gpt_icon":0},{"id":"2605709334","title":"Vyome Holdings, Inc.盘中异动 早盘大幅上涨5.97%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605709334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605709334?lang=zh_cn&edition=fundamental","pubTime":"2026-01-22 23:27","pubTimestamp":1769095657,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日23时27分,Vyome Holdings, Inc.股票出现波动,股价大幅上涨5.97%。截至发稿,该股报2.84美元/股,成交量6434股,换手率0.11%,振幅4.85%。Vyome Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.82%。其相关个股中,60 Degrees Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Io Biotech, Inc.涨幅较大,60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为11727.51%、370.41%、288.13%,振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为131.00%、69.40%、36.70%。Vyome Holdings, Inc.公司简介:Vyome Holdings Inc是一家研发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012223273897a2fc55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012223273897a2fc55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4082","HIND"],"gpt_icon":0},{"id":"2603951817","title":"Vyome Holdings, Inc.盘中异动 早盘急速拉升9.27%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603951817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603951817?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 22:33","pubTimestamp":1768487619,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日22时33分,Vyome Holdings, Inc.股票出现波动,股价急速上涨9.27%。截至发稿,该股报3.30美元/股,成交量629股,换手率0.01%,振幅6.62%。Vyome Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。其相关个股中,Cns Pharmaceuticals, Inc.、Ocular Therapeutix, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大,Gt Biopharma, Inc.、Applied Therapeutics, Inc.、Genprex, Inc.较为活跃,换手率分别为48.80%、42.49%、15.18%,振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Metavia Inc.、60 Degrees Pharmaceuticals, Inc.,振幅分别为15.65%、12.18%、11.84%。Vyome Holdings, Inc.公司简介:Vyome Holdings Inc是一家研发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115223339a4c81a8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115223339a4c81a8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4007","HIND"],"gpt_icon":0},{"id":"1137069214","title":"Vyome控股子公司LIVECHAIN INC.收购MIT孵化公司Humanyze的高级担保票据","url":"https://stock-news.laohu8.com/highlight/detail?id=1137069214","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137069214?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 21:03","pubTimestamp":1766408623,"startTime":"0","endTime":"0","summary":"Vyome控股子公司LIVECHAIN INC.将收购MIT孵化公司Humanyze的高级担保票据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4082","BK4007","LICH","HIND"],"gpt_icon":0},{"id":"2592197015","title":"Vyome Holdings, Inc.盘中异动 下午盘快速下挫6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592197015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592197015?lang=zh_cn&edition=fundamental","pubTime":"2025-12-20 03:38","pubTimestamp":1766173114,"startTime":"0","endTime":"0","summary":"北京时间2025年12月20日03时38分,Vyome Holdings, Inc.股票出现波动,股价快速跳水6.11%。截至发稿,该股报3.64美元/股,成交量1.9053万股,换手率0.34%,振幅8.19%。Vyome Holdings, Inc.股票所在的生物技术行业中,整体涨幅为1.47%。其相关个股中,Novabay Pharmaceuticals, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、爱美医疗涨幅较大,Psyence Biomedical Ltd.、In8Bio, Inc.、Neuraxis, Inc.较为活跃,换手率分别为1793.90%、224.50%、137.82%,振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Geovax Labs, Inc.,振幅分别为92.37%、59.87%、57.35%。Vyome Holdings, Inc.公司简介:Vyome Holdings Inc是一家研发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220033835953b7696&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220033835953b7696&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4007","HIND"],"gpt_icon":0},{"id":"1116502243","title":"Vyome Holdings, Inc. - 将与FDA合作设计并启动2026年重要的三期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1116502243","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116502243?lang=zh_cn&edition=fundamental","pubTime":"2025-12-08 21:13","pubTimestamp":1765199623,"startTime":"0","endTime":"0","summary":"Vyome Holdings, Inc. - 将与FDA合作设计并启动2026年重要的三期临床研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND","BK4007"],"gpt_icon":0},{"id":"1170919255","title":"Vyome公布Vt-1953最终二期试验积极结果;计划推进至FDA批准的关键研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1170919255","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170919255?lang=zh_cn&edition=fundamental","pubTime":"2025-12-08 21:12","pubTimestamp":1765199558,"startTime":"0","endTime":"0","summary":"Vyome公布Vt-1953最终二期试验积极结果;计划推进至FDA批准的关键研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4007","HIND"],"gpt_icon":0},{"id":"1175842988","title":"Vyome Holdings Inc:VT-1953治疗恶性真菌创面的二期研究获得积极中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1175842988","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175842988?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 20:32","pubTimestamp":1756989144,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc:VT-1953治疗恶性真菌创面的二期研究获得积极中期数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}